Submission Details
| 510(k) Number | K242076 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 16, 2024 |
| Decision Date | November 01, 2024 |
| Days to Decision | 108 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K242076 is an FDA 510(k) clearance for the VersaCross? RF Wire, a Catheter, Septostomy (Class II — Special Controls, product code DXF), submitted by Baylis Medical Company (Mississauga, CA). The FDA issued a Cleared decision on November 1, 2024, 108 days after receiving the submission on July 16, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5175.
| 510(k) Number | K242076 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 16, 2024 |
| Decision Date | November 01, 2024 |
| Days to Decision | 108 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXF — Catheter, Septostomy |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5175 |